Revisiting Essure--Toward Safe and Effective Sterilization - PubMed (original) (raw)
. 2015 Oct 8;373(15):e17.
doi: 10.1056/NEJMp1510514. Epub 2015 Sep 23.
Affiliations
- PMID: 26397951
- DOI: 10.1056/NEJMp1510514
Revisiting Essure--Toward Safe and Effective Sterilization
Sanket S Dhruva et al. N Engl J Med. 2015.
No abstract available
Similar articles
- Management of complications encountered with Essure hysteroscopic sterilization: a systematic review.
Adelman MR, Dassel MW, Sharp HT. Adelman MR, et al. J Minim Invasive Gynecol. 2014 Sep-Oct;21(5):733-43. doi: 10.1016/j.jmig.2014.03.019. Epub 2014 Apr 24. J Minim Invasive Gynecol. 2014. PMID: 24768959 Review. - US to require safety warnings for Essure sterilization device.
McCarthy M. McCarthy M. BMJ. 2016 Mar 3;352:i1283. doi: 10.1136/bmj.i1283. BMJ. 2016. PMID: 26941004 No abstract available. - Analysis of adverse events with Essure hysteroscopic sterilization reported to the Manufacturer and User Facility Device Experience database.
Al-Safi ZA, Shavell VI, Hobson DT, Berman JM, Diamond MP. Al-Safi ZA, et al. J Minim Invasive Gynecol. 2013 Nov-Dec;20(6):825-9. doi: 10.1016/j.jmig.2013.05.006. J Minim Invasive Gynecol. 2013. PMID: 24183273 - Placement of the Essure permanent birth control device with fluoroscopic guidance: a novel method for tubal sterilization.
McSwain H, Shaw C, Hall LD. McSwain H, et al. J Vasc Interv Radiol. 2005 Jul;16(7):1007-12. doi: 10.1097/01.RVI.0000158353.35161.90. J Vasc Interv Radiol. 2005. PMID: 16002509 - Hysteroscopic Sterilization With Essure: Summary of the U.S. Food and Drug Administration Actions and Policy Implications for Postmarketing Surveillance.
Walter JR, Ghobadi CW, Hayman E, Xu S. Walter JR, et al. Obstet Gynecol. 2017 Jan;129(1):10-19. doi: 10.1097/AOG.0000000000001796. Obstet Gynecol. 2017. PMID: 27926652
Cited by
- Essure Microinsert Abdominal Migration after Hysteroscopic Tubal Sterilization of an Appropriately Placed Essure Device: Dual Case Reports and Review of the Literature.
Rezai S, LaBine M, Gomez Roberts HA, Lora Alcantara I, Henderson CE, Elmadjian M, Nuritdinova D. Rezai S, et al. Case Rep Obstet Gynecol. 2015;2015:402197. doi: 10.1155/2015/402197. Epub 2015 Nov 18. Case Rep Obstet Gynecol. 2015. PMID: 26664781 Free PMC article. - Actividades preventivas en la mujer. Actualización PAPPS 2018.
García-Franco AL, Baeyens Fernández JA, Bailón Muñoz E, Iglesias Piñeiro MJ, Cura González ID, Del Moral AO, Landa Goñi J, Alonso Coello P, Arribas Mir L. García-Franco AL, et al. Aten Primaria. 2018 May;50 Suppl 1(Suppl 1):125-146. doi: 10.1016/S0212-6567(18)30366-4. Aten Primaria. 2018. PMID: 29866353 Free PMC article. Spanish. No abstract available. - Drugs and Medical Devices: Adverse Events and the Impact on Women's Health.
Carey JL, Nader N, Chai PR, Carreiro S, Griswold MK, Boyle KL. Carey JL, et al. Clin Ther. 2017 Jan;39(1):10-22. doi: 10.1016/j.clinthera.2016.12.009. Epub 2017 Jan 7. Clin Ther. 2017. PMID: 28069260 Free PMC article. Review. - Discordant relationship between Essure microinsert position and tubal occlusion.
Hou MY. Hou MY. BMJ Case Rep. 2016 Jul 27;2016:bcr2016216535. doi: 10.1136/bcr-2016-216535. BMJ Case Rep. 2016. PMID: 27466315 Free PMC article. - ART Outcomes After Hysteroscopic Proximal Tubal Occlusion Versus Laparoscopic Salpingectomy for Hydrosalpinx Management in Endometriosis Patients.
Maignien C, Bourdon M, Scarano-Pereira JP, Martinino A, Cheloufi M, Marcellin L, Chapron C, Santulli P. Maignien C, et al. Reprod Sci. 2022 Feb;29(2):427-435. doi: 10.1007/s43032-021-00737-6. Epub 2021 Oct 12. Reprod Sci. 2022. PMID: 34642914
MeSH terms
LinkOut - more resources
Full Text Sources
Medical